Skip to main content
Caplight Logo









Elidah

Elidah

Private
ConnecticutHealthcare & Life Scienceshttps://elidah.com

Last Round

VC Round

Apr 6, 2026

Total Funding Raised

$1.07M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Elidah operates in Healthcare & Life Sciences and is based in Connecticut. Its latest recorded funding round was a VC Round in April 2026.

Elidah is a medical device company that develops and provides non-invasive, at-home treatments for urinary incontinence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Elidah Comparables

Compare Elidah with similar companies based on industry and business-model similarity.

Elidah comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Yarlap
86%
Pelvital
84%
Athena Feminine Technologies, Inc.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Elidah Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 6, 2026
Series AJan 29, 2024
Series AJun 1, 2023
GrantJun 27, 2019
GrantJan 10, 2018
Grant
Sep 15, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Eric Kolb

CTO and Co-Founder

Founding Team

Gloria K.

CEO

Executive Team

For institutional investors. Book with your work email.

Elidah Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    $2M round raised.

  • Jan 20, 2026

    Monthly visitors grew 101% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Elidah Filings

Explore SEC and related filing metadata, where available.

Elidah filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Elidah's valuation, stock price, and market status.

Is Elidah a public or private company?

Elidah is a private company.

What is the current stock price of Elidah?

Elidah is a private company, so its shares have no public market price. Caplight tracks Elidah's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Elidah worth (valuation)?

Valuation information for Elidah is not publicly available.

Can I buy Elidah stock?

Elidah shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Elidah's last funding round?

Elidah's most recent funding round was VC Round on April 6, 2026.

Who are the main investors in Elidah?

Key investors in Elidah include Blu Venture Investors.

Will Elidah IPO soon?

No public IPO plans have been announced for Elidah.

How can I track Elidah secondary market activity?

Caplight tracks bids, offers, and trades in Elidah's shares on secondary markets.

Firmographic Details

HeadquartersConnecticut
Employee Range7
Year Founded2014
Last FundingApr 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?